Stock of The Day: What’s in Exponent, Inc. After Reaching Record High?

Stock of The Day: What's in Exponent, Inc. After Reaching Record High?

The stock of Exponent, Inc. (NASDAQ:EXPO) reached all time high today, Nov, 29 and still has $66.39 target or 7.00% above today’s $62.05 share price. This indicates more upside for the $1.59B company. This technical setup was reported by Barchart.com. If the $66.39 PT is reached, the company will be worth $111.30M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 48,302 shares traded hands. Exponent, Inc. (NASDAQ:EXPO) has risen 26.58% since April 26, 2016 and is uptrending. It has outperformed by 21.32% the S&P500.

Analysts await Exponent, Inc. (NASDAQ:EXPO) to report earnings on February, 1. They expect $0.34 earnings per share, down 5.56% or $0.02 from last year’s $0.36 per share. EXPO’s profit will be $8.71 million for 45.63 P/E if the $0.34 EPS becomes a reality. After $0.42 actual earnings per share reported by Exponent, Inc. for the previous quarter, Wall Street now forecasts -19.05% negative EPS growth.

According to Zacks Investment Research, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.”

Insitutional Activity: The institutional sentiment decreased to 1.06 in 2016 Q2. Its down 0.65, from 1.71 in 2016Q1. The ratio worsened, as 12 funds sold all Exponent, Inc. shares owned while 39 reduced positions. 19 funds bought stakes while 68 increased positions. They now own 23.37 million shares or 1.97% more from 22.92 million shares in 2016Q1.
Voya Investment Management Ltd Liability holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 13,127 shares. Great West Life Assurance Can has invested 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Nelson Van Denburg & Campbell Wealth Group Limited last reported 600 shares in the company. The Ohio-based Victory Cap Mngmt Incorporated has invested 0% in Exponent, Inc. (NASDAQ:EXPO). Raymond James Svcs Inc owns 43,004 shares or 0.02% of their US portfolio. Alliancebernstein L P last reported 0% of its portfolio in the stock. State Street accumulated 506,941 shares or 0% of the stock. Moreover, Pinebridge Investments L P has 0.01% invested in Exponent, Inc. (NASDAQ:EXPO) for 3,292 shares. Granahan Management Ma accumulated 61,144 shares or 0.13% of the stock. Louisiana State Employees Retirement Sys last reported 0.04% of its portfolio in the stock. Manufacturers Life Insurance Co The accumulated 0% or 17,359 shares. Amer Intl Gp Inc owns 19,099 shares or 0% of their US portfolio. Ubs Asset Mgmt Americas reported 51,757 shares or 0% of all its holdings. Huntington Bancorporation holds 4,430 shares or 0.01% of its portfolio. Aviance Ptnrs holds 0.09% or 4,000 shares in its portfolio.

Insider Transactions: Since June 3, 2016, the stock had 0 insider buys, and 14 selling transactions for $3.97 million net activity. Boehm Paul also sold $260,910 worth of Exponent, Inc. (NASDAQ:EXPO) shares. 342 shares were sold by Murray Steven J, worth $19,501 on Monday, October 24. 5,500 Exponent, Inc. (NASDAQ:EXPO) shares with value of $303,593 were sold by JOHNSTON PAUL R. 14,557 shares were sold by SCHLENKER RICHARD L JR, worth $829,491 on Tuesday, October 25. On Wednesday, November 9 the insider GAULKE MICHAEL R sold $238,198. Shares for $135,882 were sold by RIGGINS STEPHEN C on Tuesday, October 25. Kytomaa Harri had sold 5,500 shares worth $340,480.

More news for Exponent, Inc. (NASDAQ:EXPO) were recently published by: Forbes.com, which released: “Ex-Dividend Reminder: Waste Management, Herman Miller and Exponent” on November 28, 2016. Streetinsider.com‘s article titled: “Exponent, Inc. (EXPO) Reports In-Line Q2 EPS; Trims Outlook” and published on July 19, 2016 is yet another important article.

EXPO Company Profile

Exponent, Inc. (Exponent), incorporated on May 9, 1989, along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. The Company’s service offerings are provided on a project-by-project basis. It operates over 20 practices and centers in two operating divisions: Engineering and Other Scientific, and Environmental and Health. The Company’s Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, technology development, thermal sciences and vehicle analysis services. The Company’s Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences; epidemiology, biostatistics and computational biology; occupational and environmental health risk assessment, and toxicology and mechanistic biology. Exponent serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing and technology, among others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment